Everolimus Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 0.75 mg, 1.25 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg

Reference Brands: Zortress, Afinitor(US & EU)

Category: Immune Disorder

Everolimus tablets is available in Tablet and strengths such as 0.75 mg, 1.25 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Everolimus tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Everolimus tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Everolimus tablets, marketed as Afinitor and Zortress, are approved in the US by the FDA and in the EU via EMA for various indications including cancer and transplant rejection. Regulatory approval requires a comprehensive dossier containing clinical trial data, manufacturing details, safety, efficacy, and pharmacovigilance strategies. In the US, FDA review involves stringent evaluation of clinical and quality data, while the EMA ensures compliance with regional standards. For guidance on dossier preparation, regulatory pathways, and market accession, visit PharmaTradz. Ensuring thorough regulatory compliance is critical for the safe, effective, and timely approval of everolimus tablets worldwide, supporting optimal patient outcomes in oncology and transplantation.